Pinckney Weidinger Urban & Joyce

Delaware

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases27

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechCommunicationsMech Eng, Manuf

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/16/24	In re: Entresto (Sacubitril/Valsartan) Patent Litigation 1:20-MD-02930 ( D. DE )	REDACTED VERSION of [1528] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024)
09/16/24	In re: Entresto (Sacubitril/Valsartan) Patent Litigation 1:20-MD-02930 ( D. DE )	DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024)
09/13/24	Novartis Pharmaceuticals Corp v. Hec Pharm Co Ltd 1:20-CV-00133 ( D. DE )	STIPULATION and [Proposed] Order Regarding Amended Case Schedule by Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/13/2024)
07/09/24	Novartis Pharma Corp v. Accord Healthcare Inc 1:18-CV-01043 ( D. DE )	ORDER: HEC Pharm Co., Ltd., and HEC Pharm USA Inc.'s Motion for Recovery of Damages Under the Injunction Bond (D.I. 887 ) is DENIED. Novartis Pharmaceuticals Corporation's Motion to Strike HEC's Motion for Recovery of Damages Under the Injunction Bond (D.I. 871 ) is DENIED AS MOOT. Signed by Judge Kent A. Jordan on 7/9/2024. (jfm) (Entered: 07/09/2024)
07/09/24	Novartis Pharma Corp v. Accord Healthcare Inc 1:18-CV-01043 ( D. DE )	MEMORANDUM OPINION. Signed by Judge Kent A. Jordan on 7/9/2024. (jfm) (Entered: 07/09/2024)
	NST Global LLC v. SIG Sauer Inc 1:19-CV-00792 ( D. NH )	ENDORSED ORDER RE [75] Status Report. Text of Order: Reviewed. Further status report due January 9, 2023. So Ordered by Judge Paul J. Barbadoro.(js)
06/17/22	Novartis Pharma Corp v. Alembic Pharma Ltd 1:19-CV-02021 ( D. DE )	SO ORDERED, re (D.I. 646 in 20-md-2930-RGA. D.I. 196 in 20-cv-445-RGA. D.I. 468 in 19-cv-1979-RGA. D.I. 293 in 19-cv-2053-RGA. D.I. 174 in 19-cv-2021-RGA) STIPULATION and Proposed Order to Extend Time to submit a joint interim status report to July 7, 2022. Signed by Judge Richard G. Andrews on 6/17/2022. Associated Cases: 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA, 1:20-md-02930-RGA(nms) SO ORDERED, re (D.I. 646 in 20-md-2930-RGA. D.I. 196 in 20-cv-445-RGA. D.I. 468 in 19-cv-1979-RGA. D.I. 293 in 19-cv-2053-RGA. D.I. 174 in 19-cv-2021-RGA) STIPULATION and Proposed Order to Extend Time to submit a joint interim status report to July 7, 2022. Signed by Judge Richard G. Andrews on 6/17/2022. Associated Cases: 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA, 1:20-md-02930-RGA(nms)
06/17/22	Novartis Pharma Corp v. Alembic Pharma Ltd 1:19-CV-02021 ( D. DE )	STIPULATION and Proposed Order to Extend Time for the parties to submit a joint interim status report to July 7, 2022 - filed by Mylan Pharmaceuticals Inc. . (Palapura, Bindu) Modified on 6/17/2022 (nms).
	Novartis Pharma Corp v. Alembic Pharma Ltd 1:20-CV-00074 ( D. DE )	NOTICE OF SERVICE of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov on the Validity of the '659 Patent filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
04/20/22	Safe Driving Technologies LLC v. Ford Motor Co 1:21-CV-00064 ( D. DE )	CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) (Entered: 04/20/2022)